These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6149291)

  • 1. The effect of temperature on the alpha-adrenoceptor antagonist potency of indoramin and labetalol in the rat perfused mesenteric vascular bed.
    McAdams RP
    J Pharm Pharmacol; 1984 Sep; 36(9):628-9. PubMed ID: 6149291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of labetalol on adrenoceptors in the isolated perfused rat mesentery.
    Gulati N; Huggel H; Gulati OP
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):251-6. PubMed ID: 7436629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and postsynaptic alpha-adrenoceptor antagonism by indoramin in isolated tissues of the rat.
    Rhodes KF; Waterfall JF
    J Pharm Pharmacol; 1978 Aug; 30(8):516-7. PubMed ID: 28404
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α(1D)-Adrenoceptor regulates the vasopressor action of α(1A)-adrenoceptor in mesenteric vascular bed of α(1D)-adrenoceptor knockout mice.
    Martínez-Salas SG; Campos-Peralta JM; Pardo JP; Hernández-Muñoz R; Ibarra M; Tanoue A; Tsujimoto G; Villalobos-Molina R
    Auton Autacoid Pharmacol; 2011; 31(3-4):64-71. PubMed ID: 21951586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indoramin in rat vas deferens and aorta: concomitant alpha1-adrenoceptor and neuronal uptake blockade.
    Pupo AS; Cavenaghi DL; Campos M; Lucena Morais P; Jurkiewicz NH; Jurkiewicz A
    Br J Pharmacol; 1999 Aug; 127(8):1832-6. PubMed ID: 10482913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioregulatory properties of indoramin in the rat.
    Algate DR; Rashid S; Waterfall JF
    J Pharm Pharmacol; 1981 Apr; 33(4):236-9. PubMed ID: 6115907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
    Kennedy I; Levy GP
    Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens.
    Cohen ML; Hynes LM
    Clin Exp Hypertens A; 1983; 5(4):563-75. PubMed ID: 6133660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery.
    Hussain MB; Marshall I
    Eur J Pharmacol; 2000 Apr; 395(1):69-76. PubMed ID: 10781676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.
    Brittain RT; Drew GM; Levy GP
    Br J Pharmacol; 1982 Sep; 77(1):105-14. PubMed ID: 6127131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine.
    Bolt GR; Itoh H; Lederis K; MacCannell KL
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1147-54. PubMed ID: 2574741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed.
    Pakdeechote P; Rummery NM; Ralevic V; Dunn WR
    Eur J Pharmacol; 2007 Jun; 563(1-3):180-6. PubMed ID: 17367778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.